Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EPA to consider non-CFC inhaler market share "potential" in processing CFC exemption requests.

Executive Summary

EPA TO CONSIDER "POTENTIAL" MARKET PENETRATION OF NON-CFC CONTAINING asthma products in processing requests for exemptions for chlorofluorocarbon-containing metered-dose inhalers, Environmental Protection Agency Essential Uses Program Manager Nina Bonnelycke told the International Conference on Ozone Protection Technologies in Washington, D.C. Oct. 23. EPA is "going to include consideration of [approved, CFC-free] alternatives and their potential for market penetration in its estimate" of companies' CFC needs that it provides to the United Nations Environment Program this year, Bonnelycke said.
UsernamePublicRestriction

Register

PS029065

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel